Geography, generalisability, and susceptibility in clinical trials
dc.contributor.author | Clougherty, Jane E. | |
dc.contributor.author | Kinnee, Ellen J. | |
dc.contributor.author | Cardet, Juan Carlos | |
dc.contributor.author | Mauger, David | |
dc.contributor.author | Bacharier, Leonard | |
dc.contributor.author | Beigelman, Avraham | |
dc.contributor.author | Blake, Kathryn V. | |
dc.contributor.author | Cabana, Michael D. | |
dc.contributor.author | Castro, Mario | |
dc.contributor.author | Chmiel, James F. | |
dc.contributor.author | Covar, Ronina | |
dc.contributor.author | Fitzpatrick, Anne | |
dc.contributor.author | Gaffin, Jonathan M. | |
dc.contributor.author | Gentile, Deborah | |
dc.contributor.author | Israel, Elliot | |
dc.contributor.author | Jackson, Daniel J. | |
dc.contributor.author | Kraft, Monica | |
dc.contributor.author | Krishnan, Jerry A. | |
dc.contributor.author | Kumar, Harsha Vardhan | |
dc.contributor.author | Lang, Jason E. | |
dc.contributor.author | Lazarus, Stephen C. | |
dc.contributor.author | Lemanske, Robert F. | |
dc.contributor.author | Lima, John | |
dc.contributor.author | Martinez, Fernando D. | |
dc.contributor.author | Morgan, Wayne | |
dc.contributor.author | Moy, James | |
dc.contributor.author | Myers, Ross | |
dc.contributor.author | Naureckas, Edward T. | |
dc.contributor.author | Ortega, Victor E. | |
dc.contributor.author | Peters, Stephen P. | |
dc.contributor.author | Phipatanakul, Wanda | |
dc.contributor.author | Pongracic, Jacqueline A | |
dc.contributor.author | Ross, Kristie | |
dc.contributor.author | Sheehan, William J. | |
dc.contributor.author | Smith, Lewis J. | |
dc.contributor.author | Solway, Julian | |
dc.contributor.author | Sorkness, Christine A. | |
dc.contributor.author | Wechsler, Michael E. | |
dc.contributor.author | Wenzel, Sally | |
dc.contributor.author | White, Steven R. | |
dc.contributor.author | Holguin, Fernando | |
dc.contributor.department | Pediatrics, School of Medicine | en_US |
dc.date.accessioned | 2021-04-29T17:10:28Z | |
dc.date.available | 2021-04-29T17:10:28Z | |
dc.date.issued | 2021 | |
dc.description | This article is made available for unrestricted research re-use and secondary analysis in any form or by any means with acknowledgement of the original source. These permissions are granted for the duration of the World Health Organization (WHO) declaration of COVID-19 as a global pandemic. | en_US |
dc.eprint.version | Final published version | en_US |
dc.identifier.citation | Clougherty, J. E., Kinnee, E. J., Cardet, J. C., Mauger, D., Bacharier, L., Beigelman, A., ... & Holguin, F. (2021). Geography, generalisability, and susceptibility in clinical trials. The Lancet Respiratory Medicine, 9(4), 330-332. https://doi.org/10.1016/S2213-2600(21)00046-1 | en_US |
dc.identifier.uri | https://hdl.handle.net/1805/25811 | |
dc.language.iso | en | en_US |
dc.publisher | Elsevier | en_US |
dc.relation.isversionof | 10.1016/S2213-2600(21)00046-1 | en_US |
dc.relation.journal | The Lancet Respiratory Medicine | en_US |
dc.rights | Public Health Emergency | en_US |
dc.source | Publisher | en_US |
dc.subject | randomised clinical trials | en_US |
dc.subject | COVID-19 | en_US |
dc.subject | geography | en_US |
dc.title | Geography, generalisability, and susceptibility in clinical trials | en_US |
dc.type | Article | en_US |